drug · small molecule
patient view →bupivacaine hydrochloride
Marketedupdated 2mo agoby OncoZenge AB🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for pain and 25 investigational indications.
targets
Sodium channel protein type 4 subunit alpha
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that